A Phase II Study of KUC-7483 in Patients With Overactive Bladder

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To investigate the efficacy and safety of KUC-7483 in overactive bladder patients.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kissei Pharmaceutical Co., Ltd.
• Treatments: p-Hydroxyamphetamine

Criteria

Inclusion Criteria:

• Patients with a symptom of overactive bladder for more than 6 months.

• Patients who meet the following condition during the 3-day bladder diary period.

• the mean number of micturitions per 24 hours is ≥8 times

• the mean number of urgency episodes per 24 hours is ≥1 time

Exclusion Criteria:

• Patients who are diagnosed as stress urinary incontinence are predominant.

• Patients with urinary calculus, interstitial cystitis, or clinically significant urinary tract infection.